Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer

Journal of Clinical Oncology

Volumn 26, Issue 19, 2008, Pages 3281-3284

  Bernstein, Wendy B ^a,b   Kemp, Jean D ^a,b   Kim, Geoffrey S ^a,b   Johnson, Viviana V ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CARBOPLATIN; CYTARABINE; DOCETAXEL; GADOLINIUM; HYDROCORTISONE; KETOCONAZOLE; PREDNISONE; THALIDOMIDE; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; AGED; ARTICLE; ATAXIA; AUTOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; COGNITIVE DEFECT; DIPLOPIA; HEADACHE; HUMAN; HUMAN TISSUE; MALE; MENINGEAL METASTASIS; NAUSEA; NERVE PARALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PARESTHESIA; PRIORITY JOURNAL; PROSTATE CANCER; TRIGEMINUS NEURALGIA; CARCINOMA; CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; FATALITY; MENINGIOMA; METASTASIS; PATHOLOGY; PROSTATE TUMOR;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; MALE; MENINGEAL NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 49249085617     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.4533     Document Type: Article

References (20)

1. Kesari S, Batchelor TT: Leptomeningeal metastases. Neurol Clin 21:25-66, 2003
2. Lynes WL, Bostwick DG, Freiha FS, et al: Parenchymal brain metastases from adenocarcinoma of prostate. Urology 28:280-287, 1986
3. Taylor HG, Lefkowitz M, Skoog SJ, et al: Intracranial metastases in prostate cancer. Cancer 53:2728-2730, 1984
4. Saitoh H, Hida M, Shimbo T, et al: Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer 54:3078-3084, 1984
5. Tremont-Lukats IW, Bobustuc G, Lagos GK, et al: Brain metastasis from prostate carcinoma: The M.D. Anderson Cancer Center experience. Cancer 98:363-368, 2003
6. McCutcheon IE, Eng DY, Logothetis CJ: Brain metastasis from prostate carcinoma: Antemortem recognition and outcome after treatment. Cancer 86:2301-2311, 1999
7. Sutton MA, Watkins HL, Green LK, et al: Intracranial metastases as the first manifestation of prostate cancer. Urology 48:789-793, 1996
8. Tsai V, Kim S, Clatterbuck RE, et al: Cystic prostate metastases to the brain parenchyma: Report of two cases and review of the literature. J Neurooncol 51:167-173, 2001
9. Mintz ER, Smith GG: Autopsy findings in 100 cases of prostatic cancer. N Engl J Med 211:479-487, 1934
10. Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer: A clinical and pathologic study. Arch Neurol 30:122-137, 1974
11. DeAngelis LM, Boutros D: Leptomeningeal metastasis. Cancer Invest 23:145-154, 2005
12. Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38:51-57, 1995
13. Collie DA, Brush JP, Lammie GA, et al: Imaging features of leptomeningeal metastases. Clin Radiol 54:765-771, 1999
14. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cancer 49:759-772, 1982
15. Kaplan JG, DeSouza TG, Farkash A, et al: Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas, and leukemias. J Neurooncol 9:225-229, 1990
16. Grossman SA, Moynihan TJ: Neoplastic meningitis. Neurol Clin 9:843-856, 1991
17. Gleissner B, Chamberlain MC: Neoplastic meningitis. Lancet Neurol 5:443-452, 2006
18. Chamberlain MC: Cytologically negative carcinomatous meningitis: Usefulness of CSF biochemical markers. Neurology 50:1173-1175, 1998
19. Pentheroudakis G, Pavlidis N: Management of leptomeningeal malignancy. Expert Opin Pharmacother 6:1115-1125, 2005
20. Mencel PJ, DeAngelis LM, Motzer RJ: Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma. Cancer 73:1892-1894, 1994